03:21 AM EDT, 09/08/2025 (MT Newswires) -- Mark E Saad, Director, on September 05, 2025, sold 9,127 shares in Axsome Therapeutics ( AXSM ) for $1,141,514. Following the Form 4 filing with the SEC, Saad has control over a total of 10,302 common shares of the company, with 10,002 shares held directly and 300 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1579428/000095017025113311/xslF345X05/ownership.xml